Cargando…
Personalizing first-line treatment in advanced colorectal cancer: Present status and future perspectives
BACKGROUND: Colorectal cancer is one of the most frequent neoplasms worldwide, and the majority of patients are diagnosed in advanced stages. Metastatic colorectal cancer (mCRC) harbors several mutations with different prognostic and predictive values; KRAS, NRAS, and BRAF mutations are the best kno...
Autores principales: | Motta, Rodrigo, Cabezas-Camarero, Santiago, Torres-Mattos, Cesar, Riquelme, Alejandro, Calle, Ana, Montenegro, Paola, Sotelo, Miguel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710355/ https://www.ncbi.nlm.nih.gov/pubmed/34988329 |
Ejemplares similares
-
Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives
por: Motta, Rodrigo, et al.
Publicado: (2021) -
Glioblastoma: an organ-confined disease?
por: Cabezas-Camarero, Santiago, et al.
Publicado: (2022) -
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
por: Guerrero, Rodrigo Motta, et al.
Publicado: (2022) -
Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers
por: Cabezas-Camarero, Santiago, et al.
Publicado: (2022) -
Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer
por: Cabezas-Camarero, Santiago, et al.
Publicado: (2022)